NEW YORK (GenomeWeb News) – Biosearch Technologies said today that it has licensed H1N1 influenza signatures and the influenza A sub-typing panel signatures from the US Centers for Disease Control and Prevention.

Biosearch, based in Novato, Calif., said it is the first to license the CDC influenza signatures. The license grants Biosearch rights under the CDC patents to manufacture and sell oligonucleotides bearing the H1N1 and influenza A sub-typing signatures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.